x

Coronavirus

Six US Drugmakers Say Hydroxychloroquine Is in Short Supply,

FAIRLESS HILLS, Pa. — Six drugmakers that manufacture generic hydroxychloroquine report the drug is in short supply, while three others reported in the last week that their product is available, according to the Food and Drug Administration’s drug shortages website.

The companies cite increased demand as the cause, with some stating they expect to next ship the drug at the end of May.

President Donald Trump said Monday he has been taking hydroxychloroquine and a zinc supplement daily “for about a week and a half now,” after two White House staffers tested positive for the coronavirus. Trump has spent months pushing hydroxychloroquine as a potential cure or preventive drug for COVID-19 against the cautionary advice of many of his administration’s top medical professionals.

One of the companies, Concordia Pharmaceuticals, also makes the brand-name version, called Paquenil. It says that drug is completely unavailable but is expected to be available again at the end of this month.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Greek-American Cornell Student Rescues Man on Subway Tracks in the Bronx

NEW YORK – Greek-American Cornell University senior Bryce Demopoulos rescued a man who had fallen on the subway tracks at the Third Avenue-138 Street station on the No.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.